Schroders in talks to buy Cazenove Capital
Schroders confirmed on Friday that it was in talks to buy Cazenove Capital Holdings.
Schroders confirmed on Friday that it was in talks to buy Cazenove Capital Holdings.
The British multinational asset management company released a statement saying it was considering a cash offer for Cazenove, which manages £18.7bn in assets.
The firm has until April 19th to decide.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Schroders' assets under management would rise 10% following an acquisition.
The news comes a week after the Schroders high-profile head of UK equities, Richard Buxton, resigned.
"Schroders certainly needs to do something given the loss of Richard Buxton and other fund managers. Clearly they will need a high quality UK franchise," Numis analyst David McCann told Reuters.
Cazenove, established in 1823, is one of the top stockbrokers with Queen Elizabeth II reportedly among its clients.
The fund management arm broke away after JP Morgan formed a joint venture with Cazenove's UK investment banking business in 2005.
Schroders may have to rally up between £500m and £600m for the deal considering Cazenove's most comparative rival is valued around 3.0% of its assets under management, McCann said.
RD
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Europe’s deep creativity crisis
In the US, small companies become big ones. On this side of the Atlantic, they don’t
By David C. Stevenson Published
-
How to invest in US small caps
For more than a decade, US small caps have lagged their larger counterparts. There are signs this is starting to change – here's how to stock up
By Dr Matthew Partridge Published